2018
DOI: 10.22159/ajpcr.2018.v11i12.29939
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Pretreatment With Toll-Like Receptor 4 Antagonist Resatorvid on Methotrexate-Induced Liver Injury in Rats: Histopathological Study

Abstract: Objective: This research aims to evaluate the histopathological changes after pretreatment with resatorvid against methotrexate induced-liver injury.Methods: 28 male albino-wistar rats divided into random 4 groups (7 rats in each). Control group: Rats left untreated. Vehicle pre-treated group: Rats were administered dimethyl sulfoxide (DMSO) followed by methotrexate (MTX). Methotrexate treated group: Rats left untreated then administered MTX. Resatorvid pre-treated group: Rats were administered resatorvid foll… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 38 publications
(71 reference statements)
0
2
0
Order By: Relevance
“…These changes were attributed to MTX-induced increases in both oxidative and nitrosative stress because of exposure of the liver to high concentrations of MTX oxidative metabolites. Inhibition of the cytosolic de novo synthetic pathway for purines, pyrimidines, and polyamines by methotrexate reduces hepatic folate reservoirs, limits folate entry into mitochondria, and affects S-phase nucleic acid synthesis [27].…”
Section: Discussionmentioning
confidence: 99%
“…These changes were attributed to MTX-induced increases in both oxidative and nitrosative stress because of exposure of the liver to high concentrations of MTX oxidative metabolites. Inhibition of the cytosolic de novo synthetic pathway for purines, pyrimidines, and polyamines by methotrexate reduces hepatic folate reservoirs, limits folate entry into mitochondria, and affects S-phase nucleic acid synthesis [27].…”
Section: Discussionmentioning
confidence: 99%
“…Group 4 [Gentamicin + Resatorvid (n:7)]: Gentamicin (80 mg/kg, intraperitoneal) and resatorvid (5 mg/kg, intraperitoneal) were administered for 8 days 17,18 .…”
Section: Experimental Designmentioning
confidence: 99%